Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatocyte growth factor promotes lymphatic vessel formation and function.

Kentaro Kajiya1, Satoshi Hirakawa, Beijia Ma

  • 1Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Zurich, Zurich, Switzerland.

The EMBO Journal
|July 30, 2005
PubMed
Summary

Hepatocyte growth factor (HGF) promotes lymphatic vessel formation and function. Blocking its receptor (HGF-R) inhibits lymphatic activity, identifying HGF-R as a potential target for managing pathological lymphangiogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Translating Evidence to Practice: Advancing Equitable Access to Dermatologic Care for Radiation Dermatitis Worldwide.

International journal of radiation oncology, biology, physics·2026
Same author

Lymphangiogenesis in hypercholesterolemic skin: A comparative study of xanthomatous and non-xanthomatous lesions.

JID innovations : skin science from molecules to population health·2026
Same author

Japanese Clinical Practice Guidelines for Vascular Tumors, Vascular Malformations, Lymphatic Malformations, and Lymphangiomatosis 2022.

Journal of plastic and reconstructive surgery·2026
Same author

Deletion of Lymphatic PD-L1 Protects Mice From Severe Autoimmune Encephalitis.

European journal of immunology·2026
Same author

Japanese clinical practice guidelines for vascular tumors, vascular malformations, lymphatic malformations, and lymphangiomatosis 2022.

Surgery today·2026
Same author

Japanese clinical practice guidelines for vascular tumors, vascular malformations, lymphatic malformations, and lymphangiomatosis 2022.

Japanese journal of radiology·2026

Area of Science:

  • Vascular Biology
  • Molecular Medicine
  • Regenerative Medicine

Background:

  • Lymphatic vascular system is crucial for fluid balance and cancer spread.
  • Molecular mechanisms of lymphatic vessel formation and function are not fully understood.

Purpose of the Study:

  • To investigate the role of hepatocyte growth factor receptor (HGF-R) in lymphatic endothelial cells (LECs).
  • To identify novel factors regulating lymphangiogenesis.

Main Methods:

  • Comparative gene expression analysis of LECs and blood vascular endothelial cells (BVECs).
  • In vitro studies on cultured LECs treated with HGF.
  • In vivo studies using transgenic mice and HGF-R blockade.

Main Results:

Related Experiment Videos

  • LECs express significantly higher levels of HGF-R compared to BVECs.
  • HGF promotes LEC proliferation, migration, and tube formation in vitro.
  • HGF-R is upregulated in regenerating and inflamed lymphatic vessels.
  • HGF promotes lymphangiogenesis in vivo, while HGF-R blockade inhibits lymphatic function.

Conclusions:

  • Hepatocyte growth factor (HGF) is a potent lymphangiogenesis factor.
  • HGF-R signaling is critical for lymphatic vessel formation and function.
  • HGF-R represents a potential therapeutic target for pathological lymphangiogenesis.